These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 16721900)
21. [A 64-year old man with cognitive impairment and gait disturbance]. Ruud KJ; Scheie D; Kerty E Tidsskr Nor Laegeforen; 2007 May; 127(9):1210-1. PubMed ID: 17486712 [TBL] [Abstract][Full Text] [Related]
22. Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Ferreri AJ; Dognini GP; Campo E; Willemze R; Seymour JF; Bairey O; Martelli M; De Renz AO; Doglioni C; Montalbán C; Tedeschi A; Pavlovsky A; Morgan S; Uziel L; Ferracci M; Ascani S; Gianelli U; Patriarca C; Facchetti F; Dalla Libera A; Pertoldi B; Horváth B; Szomor A; Zucca E; Cavalli F; Ponzoni M; Haematologica; 2007 Apr; 92(4):486-92. PubMed ID: 17488659 [TBL] [Abstract][Full Text] [Related]
23. Intravascular lymphoma masquerading as multiembolic stroke developing after coronary artery by-pass surgery. Sumer M; Ozon AO; Bakar B; Cila A; Ruacan S Neurologist; 2009 Mar; 15(2):98-101. PubMed ID: 19276788 [TBL] [Abstract][Full Text] [Related]
24. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options. Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977 [TBL] [Abstract][Full Text] [Related]
25. Intravascular B-cell lymphoma: report of two cases with different clinical presentation but rapid central nervous system involvement. Anghel G; Petrinato G; Severino A; Remotti D; Insabato L; De Renzo A; Rotoli B; Majolino I Leuk Lymphoma; 2003 Aug; 44(8):1353-9. PubMed ID: 12952229 [TBL] [Abstract][Full Text] [Related]
26. Intravascular large B-cell lymphoma with cutaneous manifestations: a clinicopathologic, immunophenotypic and molecular study of three cases. Kong YY; Dai B; Sheng WQ; Yang WT; Wang CF; Kong JC; Shi DR J Cutan Pathol; 2009 Aug; 36(8):865-70. PubMed ID: 19040469 [TBL] [Abstract][Full Text] [Related]
27. Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma. Vranovsky A; Ladicka M; Lakota J Neoplasma; 2008; 55(2):107-12. PubMed ID: 18652043 [TBL] [Abstract][Full Text] [Related]
28. A clinicopathological study of 13 cases of intravascular lymphoma: experience in a single institution over a 9-yr period. Matsue K; Asada N; Takeuchi M; Yamakura M; Kimura S; Odawara J; Aoki T Eur J Haematol; 2008 Mar; 80(3):236-44. PubMed ID: 18081700 [TBL] [Abstract][Full Text] [Related]
35. High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysis. Greb A; Bohlius J; Trelle S; Schiefer D; De Souza CA; Gisselbrecht C; Intragumtornchai T; Kaiser U; Kluin-Nelemans HC; Martelli M; Milpied NJ; Santini G; Verdonck LF; Vitolo U; Schwarzer G; Engert A Cancer Treat Rev; 2007 Jun; 33(4):338-46. PubMed ID: 17400393 [TBL] [Abstract][Full Text] [Related]
36. Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab. Go A; Venugopal P; Loew J; Djordjevic D Clin Adv Hematol Oncol; 2006 Jun; 4(6):439-41. PubMed ID: 16981666 [No Abstract] [Full Text] [Related]